TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Lupin Limited ( (IN:LUPIN) ) just unveiled an update.
Lupin Limited announced that the U.S. FDA conducted a Pre-Approval Inspection at its Somerset, New Jersey manufacturing facility, which concluded with one observation. The company is committed to addressing the observation promptly to ensure compliance with CGMP standards, reflecting its dedication to maintaining high-quality manufacturing practices.
More about Lupin Limited
Lupin Limited is a pharmaceutical company that operates in the healthcare industry, focusing on the development, manufacture, and marketing of a wide range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients. The company has a significant market presence in the United States, India, and other global markets.
Average Trading Volume: 20,300
Technical Sentiment Signal: Buy
Current Market Cap: 894.1B INR
Find detailed analytics on LUPIN stock on TipRanks’ Stock Analysis page.